China Pharma Holdings (CPHI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,736 | -3,079 | -3,973 | -3,400 | -2,867 |
| Depreciation Amortization | 2,618 | 2,754 | 2,701 | 3,338 | 2,680 |
| Accounts receivable | -198 | -938 | -170 | -546 | -614 |
| Accounts payable and accrued liabilities | -302 | 570 | 505 | 83 | -229 |
| Other Working Capital | 1,196 | -396 | 878 | 52 | 30 |
| Other Operating Activity | 956 | 390 | -350 | 223 | 958 |
| Operating Cash Flow | $-466 | $-700 | $-410 | $-250 | $-42 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -38 | -12 | -402 | -438 | -867 |
| Purchase Sale Intangibles | -253 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -253 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-292 | $-12 | $-402 | $-438 | $-867 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 520 | 1,563 | 594 | 10,012 | 2,871 |
| Debt Repayment | -493 | -1,490 | -2,364 | -2,888 | -2,247 |
| Other Financing Activity | 0 | 0 | 0 | -2,527 | 0 |
| Financing Cash Flow | $27 | $73 | $-1,770 | $4,598 | $624 |
| Exchange Rate Effect | -66 | 32 | -248 | -8 | 58 |
| Beginning Cash Position | 1,424 | 2,030 | 4,859 | 958 | 1,185 |
| End Cash Position | 627 | 1,424 | 2,030 | 4,859 | 958 |
| Net Cash Flow | $-797 | $-606 | $-2,829 | $3,901 | $-227 |
| Free Cash Flow | |||||
| Operating Cash Flow | -466 | -700 | -410 | -250 | -42 |
| Capital Expenditure | -38 | -12 | -402 | -438 | -867 |
| Free Cash Flow | -505 | -711 | -812 | -688 | -910 |